Skip to content

To explore the mechanism of action of liver controlling dispersion and regulating emotions from the point of view of the liver to treat Premenstral dysphoric disorder

To explore the mechanism of action of liver controlling dispersion and regulating emotions from the point of view of the liver to treat Premenstral dysphoric disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002679
Enrollment
Unknown
Registered
2012-11-14
Start date
2012-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premenstral dysphoric disorde

Interventions

1:Baixiangdan Capsule
2:Cortex Moutan Capsule

Sponsors

Shan Dong University of Treadtional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The susbjects in line with ICD-10 depressive episode diagnostic criteria, and mild or moderate; 2. Aged 18 to 65 years; 3. The subjects with clear consciousness and independent judgment; 4. The subjects can understand the purpose of this study and voluntarily coordinate; 5. The subjects had no major diseases such as heart, liver, brain tumor and other brain disease, taking the history of psychotropic substances.

Exclusion criteria

Exclusion criteria: 1. Psychiatric patients; 2. The subjects had serious physical disease; 3. The subjects had a history of drug abuse including to take drugs treatment PMDD within three months; 4. The subjects had blood diseases; 5. The subjects were pregnant or lactating women; 6. The subjects had the symptoms of aphasia, disturbance of consciousness, dementia and other conditions; 7. The subjects had history of chronic five viscera diseases and clinical symptoms; 8. The subjects had unilateral oophorectomy or abortion within six months.

Design outcomes

Primary

MeasureTime frame
5-HT;NE;AGT ?;GC;melatonin;gastrin;HCA;progesterone;TNF-alpha;NO;

Secondary

MeasureTime frame
E2;PRL;FSH;TSH;FT3/FT;

Countries

China

Contacts

Public ContactQiao Mingqi
qmingqi@163.com+86 13553168096

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026